Diabete Type 2
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
2029
2030
Rivus PharmaceuticalsHU6
Verona PharmaGel therapy after non surgical therapy
Clinical Trials (2)
Total enrollment: 70 patients across 2 trials
Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes
Start: Nov 2023Est. completion: Mar 2025
Phase 2Withdrawn
Pocket-X Gel Non-surgical Periodontal Therapy
Start: Jun 2025Est. completion: Jan 203070 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 70 patients
2 companies competing in this space